Eculizumab as a promising treatment in thymoma-associated myasthenia gravis

被引：9

作者：

Velez-Santamaria, Valentina ^{[2
,3
]}

Nedkova, Velina ^{[3
]}

Diez, Laura ^{[3
]}

Homedes, Christian ^{[3
]}

Alberti, M. Antonia ^{[3
]}

Casasnovas, Carlos ^{[1
]}

机构：

[1] Bellvitge Univ Hosp, Neuromuscular Unit, Neurol Dept, N-N Feixa Llarga St, Barcelona 08906, Spain

[2] Bellvitge Biomed Res Inst IDIBELL, Neurometab Dis Grp, Barcelona, Spain

[3] Bellvitge Univ Hosp, Neurol Dept, Barcelona, Spain

来源：

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 2020年 / 13卷

关键词：

case report; complement inhibitor; eculizumab; myasthenia gravis; refractory; thymoma;

D O I：

10.1177/1756286420932035

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Myasthenia gravis is a chronic autoimmune disorder caused by antibodies directed against the neuromuscular junction. Some patients may have an associated thymoma, which confers a worse prognosis. Eculizumab, a monoclonal antibody that inhibits the activation of terminal complement, has recently been approved for the treatment of refractory generalized myasthenia gravis. This is an early case report of thymoma-associated refractory myasthenia gravis successfully treated with eculizumab in a real-world setting.

引用

页数：4

共 50 条

[21] A Rare Case of Thymoma-Associated Idiopathic Inflammatory Myopathy and Myasthenia Gravis
Schmoll, Chelsea
Rodenbeck, Stefanie
[J]. NEUROLOGY, 2023, 100 (17)
[22] Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
Miyawaki, Michiyo
Jikumaru, Mika
Kamada, Kosuke
Daiki, Noda
Abe, Miyuki
Anami, Kentaro
Takeuchi, Hideya
Osoegawa, Atsushi
Iwao, Sintaro
Matsubara, Etsuro
Sugio, Kenji
[J]. SURGICAL CASE REPORTS, 2021, 7 (01)
[23] Neuromyotonia in thymoma-associated myasthenia gravis: a clinico-serological study
Gastaldi, M.
de Rosa, A.
Maestri, M.
Zardini, E.
Scaranzin, S.
Guida, M.
Borrelli, P.
Ferraro, O. E.
Lampasona, V.
Furlan, R.
Irani, S.
Waters, P.
Lang, B.
Marchioni, E.
Ricciardi, R.
Franciotta, D.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 351 - 351
[24] Long-term prognosis of patients with thymoma-associated myasthenia gravis
Schalke, BCG
Schmitt, I
Marx, A
Toyka, K
MullerHermelink, HK
[J]. EPITHELIAL TUMORS OF THE THYMUS: PATHOLOGY, BIOLOGY, TREATMENT, 1997, : 329 - 335
[25] Thymoma-associated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM) with Myasthenia Gravis
Morise, Satoshi
Nakamura, Masataka
Morita, Jun-ichi
Miyake, Kousuke
Kunieda, Takenobu
Kaneko, Satoshi
Kusaka, Hirofumi
[J]. INTERNAL MEDICINE, 2017, 56 (13) : 1733 - 1737
[26] Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
Michiyo Miyawaki
Mika Jikumaru
Kosuke Kamada
Noda Daiki
Miyuki Abe
Kentaro Anami
Hideya Takeuchi
Atsushi Osoegawa
Sintaro Iwao
Etsuro Matsubara
Kenji Sugio
[J]. Surgical Case Reports, 7
[27] Report of a case of necrotizing autoimmune myopathy with thymoma-associated myasthenia gravis
Huang, Gang
Zhou, Xinhua
Yao, Dongyuan
[J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2020, 130 (11) : 1178 - 1181
[28] Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study
Gastaldi, M.
De Rosa, A.
Maestri, M.
Zardini, E.
Scaranzin, S.
Guida, M.
Borrelli, P.
Ferraro, O. E.
Lampasona, V.
Furlan, R.
Irani, S. R.
Waters, P.
Lang, B.
Vincent, A.
Marchioni, E.
Ricciardi, R.
Franciotta, D.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (07) : 992 - 999
[29] Distribution of multi-level B cell subsets in thymoma and thymoma-associated myasthenia gravis
Peng Zhang
Yuxin Liu
Si Chen
Xinyu Zhang
Yuanguo Wang
Hui Zhang
Jian Li
Zhaoyu Yang
Kai Xiong
Shuning Duan
Zeyang Zhang
Yan Wang
Ping Wang
[J]. Scientific Reports, 14
[30] Thymus in thymoma-associated myasthenia gravis - Transplantation of thymoma and extrathymomal thymic tissue into SCID mice
Sarropoulos, A
Marx, A
Hohlfeld, R
Wekerle, H
Spuler, S
[J]. EPITHELIAL TUMORS OF THE THYMUS: PATHOLOGY, BIOLOGY, TREATMENT, 1997, : 127 - 133

← 1 2 3 4 5 →